Author :   Svеrgun N.N.

Blocking PD-1/PD-L1/2 way — promising treatment strategy of patients with B-cell lymphomas (review)
Authors: Kryachok I. Novosad I.O. Khranovskaya N.M. Svеrgun N.N.... №1(17) 2015
The role of alteration of p53/MDM2 pathway regulation in neuroblastoma progression
Authors: Khranovska N.M. Inomistova M.V. Svеrgun N.N. Skachkova O.V.... №4(16) 2014
Elaboration, rationale and clinical benefit of anti-tumor vaccine therapy based on dendritic cells for patients with malignant neoplasms
Authors: Khranovskaya N.M. Kryachok I. Ganul V.L. Vorobyova L.I.... №2(14) 2014
Prognostic risk factors of unfavorable Hodgkin’s lymphoma’s run: standard and new
Authors: Novosad I.O. Kryachok I. Khranovskaya N.M. Svеrgun N.N.... №3(11) 2013
Value of molecular-genetic indexes for prognosis of chemotherapy toxicity in patients with breast cancer
Authors: Sivak L.A. Lyalkin S. Svеrgun N.N. Gubareva G.O.... №2(10) 2013
Experience of using dendritic cell autovaccine in non-small-cell lung cancer patients
Authors: Hanul A.V. Khranovskaya N.M. Sovenco V.M. Ganul V.L.... №7 (3) 2012
Biological factors of Hodgkin’s lymphoma prognosis (review)
Authors: Svеrgun N.N. Khranovskaya N.M. Kryachok I. Novosad I.O.... №6 (2) 2012
The role of high-dose chemotherapy in treatment of children with malignant solid tumors
Authors: Ionkina N.І. Sitko V. V. Shida E.V. Svеrgun N.N.... №4 (4) 2011
Role of genetic polymorphism of glutathione-S-transferase in the prediction of chemotherapy complications
Authors: Sivak L.A. Lyalkin S. Khranovskaya N.M. Filonenko Е.... №2 (2) 2011